Helsinki — September 28, 2025 — MVision AI today announced that it is working with Royal Philips on an agreement to offer MVision AI’s Contour+ Access™ AI-powered auto-contouring software with Philips CT simulators, including the recently announced Rembra RT and Areta RT systems. The proposed arrangement is intended to make guideline-based auto-contouring available directly within CT simulation workflows, helping care teams streamline planning and focus more time on patients.
Contour+ Access delivers fast and precise automatic delineation of organs-at-risk and lymph node areas. By adhering to industry best practices, Contour+ Access ensures standardized and consistent contours, facilitating treatment preparation. With Contour+ Access, all users across different clinics begin with the same guideline-based foundation.
As we work toward this agreement with Philips, our aim is simple: make guideline-based auto-contouring available directly alongside CT simulation,” said Mahmudul Hasan, Founder and CEO of MVision AI. “Embedding Contour+ Access in this way helps clinical teams reduce variability and focus more time on patient care.”
Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people’s health and well-being through meaningful innovation. Philips’ patient- and people-centric innovation leverages advanced technology and deep clinical and consumer insights to deliver personal health solutions for consumers and professional health solutions for healthcare providers and their patients in the hospital and the home.
MVision AI is a leading provider of AI-powered solutions for radiation therapy treatment planning. Our mission is to empower radiation oncology professionals with cutting-edge technology to streamline workflows, enhance treatment quality, and facilitate more patient-focused care. With a commitment to innovation and excellence, MVision AI continues to advance cancer care through the power of AI.